MCL R2 elderly

Kategorie: Indolente Lymphome/MCL

Leiter: Herr Prof. Dr. med. Martin Dreyling

EU Clinical Trials Register

EudraCT-Nr.: 2012-002542-20

Efficacy of alternating immunochemotherapy consisting of R-CHOP + R-HAD versus R-CHOP alone, followed by maintenance therapy consisting of additional lenalidomide with rituximab versus rituximab alone for older patients with mantle cell lymphoma

Herr Prof. Dr. med. Martin Dreyling

Klinikum der Universität München

E-Mail senden